Skip to main content
Caplight Logo









NovaResp Technologies Inc.

NovaResp Technologies Inc.

Private
HalifaxHealthcare & Life Scienceshttps://novaresp.ai/

Last Round

Seed

May 14, 2024

Total Funding Raised

$5.75M

Company Overview

NovaResp Technologies Inc. is a medical technology company that develops AI-powered software platforms designed to improve the treatment of obstructive sleep apnea by integrating with existing CPAP machines to provide personalized, comfortable therapy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Healthcare Analytics, Health IoT

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

medical AIsleep apneaCPAPpositive airway pressurePAPdigital healthpredictive softwaremedtechrespiratory healthhealth IoTpatient adherenceAI-enabled medical devicesmart CPAPhealthcare analyticswearable medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NovaResp Technologies Inc. Comparables

Compare NovaResp Technologies Inc. with similar companies based on industry and business-model similarity.

NovaResp Technologies Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
sovaSage
66%
Philips
64%
React Health
63%

NovaResp Technologies Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 14, 2024
DebtJan 27, 2023
SeedJan 26, 2023
SeedJun 1, 2021
GrantMar 31, 2021
Pre Seed
Mar 31, 2020

NovaResp Technologies Inc. Investors

Notable investors and investment history

NovaResp Technologies Inc. investors
InvestorRounds
InnovacorpGrant
InnovacorpPre Seed, Seed, Grant
Atlantic Canada Opportunities AgencyDebt, Grant
MitacsGrant
Concrete VenturesSeed
Centre for Aging and Brain Health InnovationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 30, 2024

    Monthly visitors increased 45% MoM.

  • May 14, 2024

    $2.2M round with Concrete Ventures and Innovacorp.

NovaResp Technologies Inc. Filings

Explore SEC and related filing metadata, where available.

NovaResp Technologies Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NovaResp Technologies Inc.'s valuation, stock price, and market status.

Is NovaResp a public or private company?

NovaResp is a private company.

What is the current stock price of NovaResp?

NovaResp is a private company with no public stock price. No recent secondary market data is available.

How much is NovaResp worth (valuation)?

Valuation information for NovaResp is not publicly available.

Can I buy NovaResp stock?

NovaResp shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NovaResp's last funding round?

NovaResp's most recent funding round was Seed on May 14, 2024.

Who are the main investors in NovaResp?

Key investors in NovaResp include Concrete Ventures.

Will NovaResp IPO soon?

No public IPO plans have been announced for NovaResp.

How can I track NovaResp secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NovaResp's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHalifax
Employee Range15
Year Founded2016
Last FundingMay 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?